Ameriprise Financial Inc Champions Oncology, Inc. Transaction History

Ameriprise Financial Inc

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$4.56 - $6.59 $41,236 - $59,593	-9,043 Reduced 10.75%	75,044 $421,000
Q3 2023 Nov 14, 2023	SELL	$5.2 - $7.32 $3,868 - $5,446	-744 Reduced 0.88%	84,087 $522,000
Q2 2023 Aug 14, 2023	BUY	$4.11 - $6.81 $16,666 - $27,614	4,055 Added 5.02%	84,831 $541,000
Q4 2022 Feb 14, 2023	SELL	$3.75 - $7.69 $3,438 - $7,051	-917 Reduced 1.12%	80,776 $364,000
Q3 2022 Nov 14, 2022	SELL	$7.21 - $9.47 $17,909 - $23,523	-2,484 Reduced 2.95%	81,693 $613,000
Q2 2022 Aug 15, 2022	SELL	$6.81 - $8.31 $5,945 - $7,254	-873 Reduced 1.03%	84,177 $681,000
Q1 2022 May 16, 2022	BUY	$7.26 - $8.53 $14,650 - $17,213	2,018 Added 2.43%	85,050 $692,000
Q4 2021 Feb 14, 2022	BUY	$7.76 - $10.23 $644,328 - $849,417	83,032 New	83,032 $664,000

5.81M

3.3K

6.1K

Ticker CSBR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 13,522,400
Market Cap $53.7M
Description
Champions Oncology, Inc. develops and sells technology solutions and products to personalize the development and use of oncology drugs in the United States. Its Tumorgraft Technology Platform is an approach to personalizing cancer care based upon the implantation of human tumors in immune-deficient mice. The company, through its Tumorgraft Techn...

Get notified when there are updates to the investment portfolio of Ameriprise Financial Inc, based on Form 13F filings with the SEC.

Stay updated on Ameriprise Financial Inc with notifications on news.